National Lab Briefs

The Department of Energy and the University of California have gone on the offensive to head off an effort by antinuclear activists to end a 45-year relationship between the state university and the nation's nuclear weapons laboratories. DOE, in an attempt to appease university faculty who are unhappy with the labs, has added $5 million to the system's current five-year contract to operate Lawrence Livermore and Los Alamos national labs, with the money going to non-nuclear research and a campu


Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Department of Energy and the University of California have gone on the offensive to head off an effort by antinuclear activists to end a 45-year relationship between the state university and the nation's nuclear weapons laboratories. DOE, in an attempt to appease university faculty who are unhappy with the labs, has added $5 million to the system's current five-year contract to operate Lawrence Livermore and Los Alamos national labs, with the money going to non-nuclear research and a campus-based program in peace studies. And the UC system, under pressure from the state legislature, is getting ready to appoint three overseers from among a pool of current and past lab employees to watch for flawed or distorted research. UC officials hope the moves will placate critics and convince the university's Board of Regents, which must decide next year, to continue UC oversight of the labs. But opponents say the moves ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio